by Haja Mo April 1, 2026 Business Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug. Previous Story Oil and Gas Prices Continue to Rise in Choppy Trade Next Story Global Ban on Digital Duties Expires After Stalled Talks at W.T.O.
